1-3 of 3
Alessandro Pulsoni
Close
Sort by
Journal Articles

Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey

Caterina Giovanna Valentini, Alfonso Piciocchi, Fabio Facchetti, Fabio Guolo, Alessandro Pulsoni, Marco Vignetti, Livio Pagano
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5608–5611.
https://doi.org/10.1182/bloodadvances.2021005802
Published: 2021
Journal Articles

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial

Clinical Trials & Observations
Umberto Ricardi, Mario Levis, Andrea Evangelista, Daniela Maria Gioia, Gian Mauro Sacchetti, Manuel Gotti, Alessandro Re, Michela Buglione, Vincenzo Pavone, Antonio Nardella, Luca Nassi, Manuela Zanni, Paola Franzone, Giovanni Piero Frezza, Alessandro Pulsoni, Lavinia Grapulin, Armando Santoro, Luigi Rigacci, Gabriele Simontacchi, Monica Tani, Francesco Zaja, Elisabetta Abruzzese, Barbara Botto, Vittorio Ruggero Zilioli, Delia Rota-Scalabrini, Roberto Freilone, Giovannino Ciccone, Andrea Riccardo Filippi, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4504–4514.
https://doi.org/10.1182/bloodadvances.2021005150
Published: 2021
Includes: Supplemental data
Journal Articles

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Manuela Zanni, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, Francesca Ricci, Carmelo Carlo-Stella
Journal: Blood Advances
Blood Adv (2020) 4 (1): 136–140.
https://doi.org/10.1182/bloodadvances.2019000984
Published: 2020
Includes: Supplemental data